NASDAQ:NARI Inari Medical (NARI) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free NARI Stock Alerts $45.90 -0.98 (-2.09%) (As of 06/13/2024 ET) Add Compare Share Share Today's Range$44.92▼$47.2050-Day Range$37.11▼$50.6952-Week Range$36.73▼$71.85Volume494,105 shsAverage Volume1.10 million shsMarket Capitalization$2.67 billionP/E RatioN/ADividend YieldN/APrice Target$65.71 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Inari Medical alerts: Email Address Inari Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.71 Rating ScoreUpside/Downside43.2% Upside$65.71 Price TargetShort InterestHealthy9.04% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.08Based on 22 Articles This WeekInsider TradingSelling Shares$8.91 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.41) to $0.20 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.57 out of 5 starsMedical Sector250th out of 917 stocksSurgical & Medical Instruments Industry36th out of 100 stocks 4.4 Analyst's Opinion Consensus RatingInari Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageInari Medical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inari Medical's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted9.04% of the float of Inari Medical has been sold short.Short Interest Ratio / Days to CoverInari Medical has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inari Medical has recently decreased by 7.44%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldInari Medical does not currently pay a dividend.Dividend GrowthInari Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NARI. Previous Next 2.3 News and Social Media Coverage News SentimentInari Medical has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 22 news articles for Inari Medical this week, compared to 6 articles on an average week.Search Interest6 people have searched for NARI on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Inari Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inari Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,909,434.00 in company stock.Percentage Held by Insiders10.60% of the stock of Inari Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions90.98% of the stock of Inari Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inari Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Inari Medical are expected to grow in the coming year, from ($0.41) to $0.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inari Medical is -111.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inari Medical is -111.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInari Medical has a P/B Ratio of 5.69. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Inari Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Freeport SocietyA Silent Invasion of AmericaThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.Go here to see why. About Inari Medical Stock (NASDAQ:NARI)Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Read More NARI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NARI Stock News HeadlinesMay 31, 2024 | insidertrades.comInsider Selling: Inari Medical, Inc. (NASDAQ:NARI) CEO Sells 3,000 Shares of StockMay 22, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) Director Sells $43,755.96 in StockMay 19, 2024 | insidertrades.comWilliam Hoffman Sells 40,000 Shares of Inari Medical, Inc. (NASDAQ:NARI) StockMay 17, 2024 | insidertrades.comMitch C. Hill Sells 6,000 Shares of Inari Medical, Inc. (NASDAQ:NARI) StockMay 16, 2024 | insidertrades.comInari Medical, Inc. (NASDAQ:NARI) CFO Mitch C. Hill Sells 6,000 SharesJune 13 at 8:02 PM | prnewswire.comNARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud LawsuitJune 13 at 7:16 PM | globenewswire.comInari Medical Faces Lengthy DOJ Probe and Investor Suit Over Potential Kickbacks to Doctors– Hagens BermanJune 13 at 11:46 AM | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari Medical, Inc. – NARIJune 12 at 10:33 PM | globenewswire.comINARI MEDICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARIJune 12 at 11:00 AM | globenewswire.comNARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law FirmJune 11 at 10:32 PM | globenewswire.comINARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARIJune 11 at 8:50 PM | businesswire.comRosen Law Firm Urges Inari Medical, Inc. (NARI) Stockholders with Large Losses to Contact the Firm for Information About Their RightsJune 11 at 7:19 PM | prnewswire.comSecurities Fraud Class Action Lawsuit Was Filed Against Inari Medical, Inc. (NARI) Investors - Contact Kessler Topaz Meltzer & Check, LLPJune 11 at 12:00 PM | prnewswire.comNARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud LawsuitJune 10, 2024 | globenewswire.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARIJune 10, 2024 | globenewswire.comInari Medical, Inc. (NARI) Litigation Initiated After NARI Disclosed DOJ Probe of Business Practices – Hagens BermanJune 10, 2024 | globenewswire.comINARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inari Medical, Inc.June 10, 2024 | globenewswire.comNARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inari Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!June 10, 2024 | prnewswire.comInari Medical, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before July 12, 2024 to Discuss Your Rights - NARIJune 8, 2024 | globenewswire.comNARI Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Inari Medical, Inc. Investors with Losses to Contact the FirmJune 7, 2024 | prnewswire.comINARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARIJune 7, 2024 | prnewswire.comNARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud LawsuitJune 7, 2024 | globenewswire.comInvestors in Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights – NARIJune 7, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari Medical, Inc. - NARIJune 6, 2024 | prnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARISee More Headlines Receive NARI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today6/14/2024Next Earnings (Estimated)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NARI CUSIPN/A CIK1531048 Webwww.inarimedical.com Phone877-923-4747FaxN/AEmployees1,300Year FoundedN/APrice Target and Rating Average Stock Price Target$65.71 High Stock Price Target$84.00 Low Stock Price Target$50.00 Potential Upside/Downside+43.2%Consensus RatingModerate Buy Rating Score (0-4)2.71 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,640,000.00 Net Margins-4.54% Pretax Margin-2.04% Return on Equity-1.65% Return on Assets-1.23% Debt Debt-to-Equity RatioN/A Current Ratio2.71 Quick Ratio2.19 Sales & Book Value Annual Sales$520.66 million Price / Sales5.13 Cash Flow$0.09 per share Price / Cash Flow526.46 Book Value$8.07 per share Price / Book5.69Miscellaneous Outstanding Shares58,138,000Free Float51,975,000Market Cap$2.67 billion OptionableOptionable Beta1.02 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Andrew J. Hykes (Age 51)CEO, President & Director Comp: $1.54MMr. Mitchell C. Hill (Age 65)Chief Financial Officer Comp: $864.63kDr. Thomas M. Tu M.D. (Age 51)Chief Medical Officer Comp: $865.63kMr. Paul A. Koehn (Age 61)Senior Vice President of Operations Mr. Kevin StrangeSenior Vice President of Finance, Accounting, Strategy & Business DevelopmentMr. John Hsu C.F.A.Vice President of Investor RelationsMs. Angela AhmadGeneral Counsel & SecretaryMr. Eric KhairySenior Vice President of MarketingMr. Tim BennerSenior VP of Sales & Senior VP of U.S. SalesMs. Tara DunnSenior VP & GM of LimFlowMore ExecutivesKey CompetitorsNuVasiveNASDAQ:NUVACantel MedicalNYSE:CMDTeleflexNYSE:TFXSolventumNYSE:SOLVGlobus MedicalNYSE:GMEDView All CompetitorsInsiders & InstitutionsWilliam HoffmanSold 60,000 sharesTotal: $3.01 M ($50.13/share)Andrew HykesSold 3,000 sharesTotal: $150,000.00 ($50.00/share)Rebecca ChambersSold 964 sharesTotal: $43,755.96 ($45.39/share)iA Global Asset Management Inc.Bought 42,680 shares on 5/17/2024Ownership: 0.166%Motley Fool Asset Management LLCBought 21,582 shares on 5/17/2024Ownership: 0.113%View All Insider TransactionsView All Institutional Transactions NARI Stock Analysis - Frequently Asked Questions Should I buy or sell Inari Medical stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NARI shares. View NARI analyst ratings or view top-rated stocks. What is Inari Medical's stock price target for 2024? 7 Wall Street analysts have issued twelve-month target prices for Inari Medical's stock. Their NARI share price targets range from $50.00 to $84.00. On average, they predict the company's stock price to reach $65.71 in the next year. This suggests a possible upside of 43.2% from the stock's current price. View analysts price targets for NARI or view top-rated stocks among Wall Street analysts. How have NARI shares performed in 2024? Inari Medical's stock was trading at $64.92 at the start of the year. Since then, NARI shares have decreased by 29.3% and is now trading at $45.90. View the best growth stocks for 2024 here. When is Inari Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024. View our NARI earnings forecast. How were Inari Medical's earnings last quarter? Inari Medical, Inc. (NASDAQ:NARI) issued its quarterly earnings data on Tuesday, April, 30th. The company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.11) by $0.15. The business earned $143.19 million during the quarter, compared to analyst estimates of $138.32 million. Inari Medical had a negative trailing twelve-month return on equity of 1.65% and a negative net margin of 4.54%. What ETFs hold Inari Medical's stock? ETFs with the largest weight of Inari Medical (NASDAQ:NARI) stock in their portfolio include MFAM Small-Cap Growth ETF (MFMS), Motley Fool Small-Cap Growth ETF (TMFS), Clough Select Equity ETF (CBSE), Tema Cardiovascular and Metabolics ETF (HRTS), Clough Long/Short Equity ETF (CBLS), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE) and AlphaMark Actively Managed Small Cap ETF (SMCP). What guidance has Inari Medical issued on next quarter's earnings? Inari Medical updated its FY 2024 earnings guidance on Tuesday, April, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $592.5 million-$602.5 million, compared to the consensus revenue estimate of $588.4 million. What other stocks do shareholders of Inari Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY). When did Inari Medical IPO? Inari Medical (NARI) raised $110 million in an IPO on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers. Who are Inari Medical's major shareholders? Inari Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.63%), Bamco Inc. NY (1.34%), Brown Capital Management LLC (0.90%), Price T Rowe Associates Inc. MD (0.64%), Jennison Associates LLC (0.59%) and Principal Financial Group Inc. (0.53%). Insiders that own company stock include Andrew Hykes, Donald B Milder, Mitch C Hill, Mitch C Hill, Rebecca Chambers, Stanley Tang, Thomas Tu and William Hoffman. View institutional ownership trends. How do I buy shares of Inari Medical? Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NARI) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inari Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.